1 completed, 1 recruiting. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow Fibrosis Lung: new trials by email Literature Review of Fibrosis Lung trials Research Report on Fibrosis Lung
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Development of FAPI PET as a Non-invasive Biomarker of Pulmonary Fibrogenesis FAPI tracer, PET/MRI - Fibrosis Lung | Phase 2 | Recruiting | University of Wisconsin, Madison | 50 | 2025-11-19 | 2026-10-01 |
| Pilot Study to Assess Efficacy and Safety of Treamid in the Rehabilitation of Patients After COVID-19 Pneumonia Treamid, Placebo - SARS-CoV-2 Infection, Fibrosis Lung | Phase 2 | Completed | PHARMENTERPRISES LLC | 60 | 2020-09-01 | 2021-04-05 |
Pulmonary Fibrosis (2) · COVID-19 (1) · Coronavirus Infections (1)
Fibrosis (2) · Lung Diseases (2) · Lung Diseases, Interstitial (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Respiratory Tract Diseases (2) · Coronaviridae Infections (1) · Infections (1) · Nidovirales Infections (1) · Pneumonia (1) · Pneumonia, Viral (1) · RNA Virus Infections (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
N,N'-bis(2-(1H-imidazol-2-yl)ethyl)pentanediamide (1)
PHARMENTERPRISES LLC (1) · University of Wisconsin, Madison (1)
Russia (1) · United States (1)
Ali Pirasteh, MD (1)